Abstract: Novel crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form V, Form VI, Form VII, Form VIII, Form IX, Form X, Form XI, Form XII, Form XIII, Form XIV, Form XV, Form XVI, Form XVII, Form XVIII, and Form XIX are characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, and Alzheimer's disease.

Abstract: An electromechanical braking system for an aircraft, including a first power conversion module (PCM) and a second power conversion module (PCM), each configured to receive power from a respective independent power source on the aircraft. The system further includes at least one brake system control unit (BSCU) for converting an input brake command signal into a brake clamp force command signal. At least a first brake control module (BCM) and a second brake control module (BCM) are provided, each configured to receive the brake clamp force command signal from the at least one BSCU and to output a primary brake clamp force command signal and an alternate brake clamp force command signal based on the received brake clamp force command signal. A first electromechanical actuator controller (EMAC) and a second electromechanical actuator controller (EMAC) are provided, each configured to convert a brake clamp force command signal to at least one electromechanical actuator drive control signal.

Abstract: According to the present invention, an electromechanical braking system is provided. The braking system includes at least one brake system control unit (BSCU) for converting an input brake command signal into a brake clamp force command signal. In addition, the braking system includes a first electromechanical actuator controller (EMAC) and a second electromechanical actuator controller (EMAC) configured to receive the brake clamp force command signal from the at least one BSCU and to convert the brake clamp force command signal to at least one electromechanical actuator drive control signal. Further, the braking system includes at least one electromechanical actuator configured to receive the at least one drive control signal and to apply a brake clamp force to at least one wheel to be braked in response to the at least one drive control signal. Moreover, the first EMAC and the second EMAC are configured to perform antiskid control in relation to the at least one wheel to be braked.

Abstract: Novel crystalline forms of [R—(R*,R*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form V, Form VI, Form VII, Form VIII, Form IX, Form X, Form XI, Form XII, Form XIII, Form XIV, Form XV, Form XVI, Form XVII, Form XVIII, and Form XIX are characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, and Alzheimer's disease.

Abstract: Novel crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form V, Form VI, Form VII, Form VIII, Form IX, Form X, Form XI, Form XII, Form XIII, Form XIV, Form XV, Form XVI, Form XVII, Form XVIII, and Form XIX are characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, and Alzheimer's disease.

Abstract: A method to evaluate anti-money laundering risk may include identifying a person or other legal entity to be evaluated. A country may be selected associated with the person or other legal entity. At least one financial product or financial instrument associated with the person or other legal entity may be selected. The method may also include selecting a customer type associated with the person or other legal entity. A risk rating may be determined based on responses to predetermined criteria related to the selected country, the at least one selected financial product and the selected customer type.

Abstract: Novel crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form V, Form VI, Form VII, Form VIII, Form IX, Form X, Form XI, Form XII, Form XIII, Form XIV, Form XV, Form XVI, Form XVII, Form XVIII, and Form XIX are characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, and Alzheimer's disease.

Abstract: Novel crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form V, Form VI, Form VII, Form VIII, Form IX, Form X, Form XI, Form XII, Form XIII, Form XIV, Form XV, Form XVI, Form XVII, Form XVIII, and Form XIX are characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, and Alzheimer's disease.

Abstract: A method for accessing and storing data in randomly assigned storage locations in a memory associated with a processor under the control of external circuits connected to the processor I/O bus, said external circuits being provided with registers for storing several assigned addresses in the memory which contain the starting addresses in the memory of a control list stored in a plurality of sequential addresses and five or more storage areas, each including a plurality of contiguous storage locations and further provision being made within the said processor for incrementing the addresses stored in the said assigned addresses each time they are accessed for performing a reading or writing operation in the memory location designated therein.

Abstract: A general purpose ophthalmic lens series incorporating an aspheric, atoric design concept which allows the selection of lens base curves substantially independently of traditional field of view or marginal error performance criteria. Factors of sensitivity of field errors to fitting distance, shape magnification, geometric distortion, eyelash clearance, reflections, applicability to large spectacle frames and general cosmetic appearance are optimized by base curve selection and field corrections are attended to by aspherizing one or both surfaces of the lenses.